PubMed

Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice.

Flyvbjerg A, Denner L, Schrijvers BF, Tilton RG, Mogensen TH, Paludan SR, Rasch R.

Diabetes. 2004 Jan;53(1):166-72.PMID: 14693711 [PubMed - indexed for MEDLINE]Related articlesFree article

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.

Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R.

Diabetes. 2002 Oct;51(10):3090-4.PMID: 12351452 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.

Jensen LJ, Denner L, Schrijvers BF, Tilton RG, Rasch R, Flyvbjerg A.

J Endocrinol. 2006 Mar;188(3):493-501.PMID: 16522729 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.

Schrijvers BF, De Vriese AS, Tilton RG, Van de Voorde J, Denner L, Lameire NH, Flyvbjerg A.

Horm Metab Res. 2005 Jan;37(1):21-5.PMID: 15702434 [PubMed - indexed for MEDLINE]Related articles

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K.

Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8015-20.PMID: 10859350 [PubMed - indexed for MEDLINE]Related articlesFree article

RAGE mRNA expression in the diabetic mouse kidney.

Ziyadeh FN, Cohen MP, Guo J, Jin Y.

Mol Cell Biochem. 1997 May;170(1-2):147-52.PMID: 9144329 [PubMed - indexed for MEDLINE]Related articles

Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.

Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, Suzuki Y, Wang LN, Horikoshi S, Tomino Y.

Nephrol Dial Transplant. 2004 Dec;19(12):3012-20.PMID: 15574998 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes.

Schrijvers BF, De Vriese AS, Van de Voorde J, Rasch R, Lameire NH, Flyvbjerg A.

Nephrol Dial Transplant. 2004 May;19(5):1092-7. Epub 2004 Feb 19.PMID: 14993490 [PubMed - indexed for MEDLINE]Related articlesFree article

RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes.

Wendt T, Harja E, Bucciarelli L, Qu W, Lu Y, Rong LL, Jenkins DG, Stein G, Schmidt AM, Yan SF.

Atherosclerosis. 2006 Mar;185(1):70-7. Epub 2005 Aug 1.PMID: 16076470 [PubMed - indexed for MEDLINE]Related articles

Urocortin ameliorates diabetic nephropathy in obese db/db mice.

Li X, Hu J, Zhang R, Sun X, Zhang Q, Guan X, Chen J, Zhu Q, Li S.

Br J Pharmacol. 2008 Jul;154(5):1025-34. Epub 2008 Apr 21.PMID: 18587447 [PubMed - indexed for MEDLINE]Related articlesFree article

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.

Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH.

Kidney Int. 2004 Jan;65(1):116-28.PMID: 14675042 [PubMed - indexed for MEDLINE]Related articles

Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.

Cohen MP, Sharma K, Jin Y, Hud E, Wu VY, Tomaszewski J, Ziyadeh FN.

J Clin Invest. 1995 May;95(5):2338-45.PMID: 7738197 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of decline in renal function in the diabetic db/db mouse.

Cohen MP, Clements RS, Cohen JA, Shearman CW.

Diabetologia. 1996 Mar;39(3):270-4.PMID: 8721771 [PubMed - indexed for MEDLINE]Related articles

2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.

Ichinose K, Maeshima Y, Yamamoto Y, Kinomura M, Hirokoshi K, Kitayama H, Takazawa Y, Sugiyama H, Yamasaki Y, Agata N, Makino H.

Diabetes. 2006 May;55(5):1232-42.PMID: 16644677 [PubMed - indexed for MEDLINE]Related articlesFree article

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.

Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM.

Am J Pathol. 2003 Apr;162(4):1123-37.PMID: 12651605 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice.

Tanimoto M, Fan Q, Gohda T, Shike T, Makita Y, Tomino Y.

Metabolism. 2004 Nov;53(11):1473-9.PMID: 15536604 [PubMed - indexed for MEDLINE]Related articles

A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.

Schrijvers BF, Flyvbjerg A, Tilton RG, Lameire NH, De Vriese AS.

Nephrol Dial Transplant. 2006 Feb;21(2):324-9. Epub 2005 Oct 25.PMID: 16249198 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice.

Collins SJ, Alexander SL, Lopez-Guisa JM, Cai X, Maruvada R, Chua SC, Zhang G, Okamura DM, Matsuo S, Eddy AA.

Nephron Exp Nephrol. 2006;104(1):e23-34. Epub 2006 May 1.PMID: 16735799 [PubMed - indexed for MEDLINE]Related articles

Effects of aminoguanidine on serum advanced glycation endproducts, urinary albilmin excretion, mesangial expansion, and glomerular basement membrane thickening in Otsuka Long-Evans Tokushima fatty rats.

Yamauchi A, Takei I, Makita Z, Nakamoto S, Ohashi N, Kiguchi H, Ishii T, Koike T, Saruta T.

Diabetes Res Clin Pract. 1997 Jan;34(3):127-33.PMID: 9069563 [PubMed - indexed for MEDLINE]Related articles

Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.

Cohen MP, Masson N, Hud E, Ziyadeh F, Han DC, Clements RS.

Exp Nephrol. 2000 May-Jun;8(3):135-43.PMID: 10810230 [PubMed - indexed for MEDLINE]Related articles